Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | TP53 | P04637 | 2/20 | 0.54 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.53 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.49 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.49 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.49 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.49 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.49 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.49 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30501657 | 1.00 | NPC1 (0.54) | NPC1RAB9ATP53HSD17B1HSD17B2 | |
| SCHEMBL18573516 | 0.87 | ESRRG (0.63) | NPC1RAB9ATP53HSD17B1HSD17B2 | |
| SCHEMBL20764031 | 0.81 | HDAC3 (0.54) | NPC1RAB9ATP53LMNASMN1; SMN2 | |
| SCHEMBL23091265 | 0.81 | HDAC3 (0.74) | NPC1RAB9ATP53LMNAKDM4E | |
| SCHEMBL30501748 | 0.81 | HDAC3 (0.74) | NPC1RAB9ATP53LMNAKDM4E | |
| SCHEMBL20764070 | 0.79 | SIRT2 (0.63) | NPC1RAB9ATP53LMNAKDM4E | |
| SCHEMBL20764075 | 0.78 | SMN1; SMN2 (0.56) | NPC1RAB9ATP53LMNAKDM4E | |
| SCHEMBL23091169 | 0.78 | NPC1 (0.64) | NPC1RAB9ATP53LMNAKDM4E | |
| SCHEMBL30501668 | 0.78 | NPC1 (0.64) | NPC1RAB9ATP53LMNAKDM4E | |
| SCHEMBL20764073 | 0.78 | NPC1 (0.72) | NPC1RAB9ATP53LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3805210-B1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | AUTOPHAGYSCIENCES INC (KR) | 2023-11-29 | — | — | EP | claimed |
| CN-112004807-B | Compounds and pharmaceutical compositions comprising the same | 自体吞噬科学有限公司 | 2023-07-18 | — | — | CN | claimed |
| US-11407744-B2 | Compound and pharmaceutical composition comprising same | Autophagysciences Inc. (KR) | 2022-08-09 | — | — | US | claimed |
| EP-3805210-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Autophagysciences, Inc (KR) | 2021-04-14 | — | — | EP | claimed |
| US-20210078987-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Autophagysciences Inc. (KR) | 2021-03-18 | — | — | US | claimed |
| EP-3805210-B1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | AUTOPHAGYSCIENCES INC (KR) | 2023-11-29 | — | — | EP | disclosed |
| EP-3805210-B1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | AUTOPHAGYSCIENCES INC (KR) | 2023-11-29 | — | — | EP | disclosed |
| CN-112004807-B | Compounds and pharmaceutical compositions comprising the same | 自体吞噬科学有限公司 | 2023-07-18 | — | — | CN | disclosed |
| US-11407744-B2 | Compound and pharmaceutical composition comprising same | Autophagysciences Inc. (KR) | 2022-08-09 | — | — | US | disclosed |
| EP-3805210-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Autophagysciences, Inc (KR) | 2021-04-14 | — | — | EP | disclosed |
| US-20210078987-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Autophagysciences Inc. (KR) | 2021-03-18 | — | — | US | disclosed |
| US-20210078987-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Autophagysciences Inc. (KR) | 2021-03-18 | — | — | US | disclosed |
| CN-112004807-A | Novel compounds and pharmaceutical compositions comprising said compounds | 自体吞噬科学有限公司 | 2020-11-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11407744-B2 | Compound and pharmaceutical composition comprising same | TFEB, ATG7, BECN1 | NPC1 24/4885RAB9A 248/4885TP53 224/4885 |
| US-20210078987-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | TFEB, ATG7, BECN1 | NPC1 25/4885RAB9A 194/4885TP53 369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.